— Know what they know.
Not Investment Advice

CELG-RI NYSE

Bristol-Myers Squibb Company Ce
1W: +18.1% 1M: -12.7% 3M: +29.2% YTD: +62.2% 1Y: +289.2% 3Y: -7.7%
$0.13
+0.02 (+17.45%)
 
Weekly Expected Move ±23.1%
$0 $0 $0 $0 $0
NYSE · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 46 · $263.9M mcap · 2.04B float · 0.0008% daily turnover

📊 Key Metrics

TTM
$48B
Revenue
+1.8% YoY
$7B
Net Income
+34.2% YoY
$12B
Free Cash Flow
-9.0% YoY
70.2%
Gross Margin
32.9%
Op. Margin
23.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.8%
ROA8.1%
ROIC20.8%

Valuation

P/E0.0
P/B0.0
EV/EBITDA2.2

Leverage

Debt/Equity2.31
Current Ratio1.42
Interest Cov.7.3x

Quality Scores

Piotroski F8/9
Altman Z1.48
Beneish M-3.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms